Open Scanner

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Cyclo Therapeutics Inc

CYTH
Current price
1.17 USD -0.07 USD (-5.65%)
Last closed 1.24 USD
Sector Healthcare
Industry Drug Manufacturers - Specialty & Generic
Exchange NASDAQ
Capitalization 33 478 846 USD
Yield for 12 month -44.81 %
1Y
3Y
5Y
10Y
15Y
CYTH
21.11.2021 - 28.11.2021

Cyclo Therapeutics, Inc., a clinical stage biotechnology company, engages in the development of cyclodextrin-based products for the treatment of neurodegenerative diseases. The company's lead drug candidate is Trappsol Cyclo (hydroxypropyl beta cyclodextrin), an orphan drug, which is in Phase III clinical trials for the treatment of Niemann-Pick Type C disease; and in Phase IIb clinical trials for the treatment of Alzheimer's disease. It also sells cyclodextrins and related products to the pharmaceutical, nutritional, and other industries, primarily for use in diagnostics and specialty drugs. The company was formerly known as CTD Holdings, Inc. and changed its name to Cyclo Therapeutics, Inc. in September 2019. Cyclo Therapeutics, Inc. was incorporated in 1990 and is headquartered in Gainesville, Florida. Address: 6714 NW 16th Street, Gainesville, FL, United States, 32653

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

3.2 USD

P/E ratio

Dividend Yield

Current Year

+1 076 405 USD

Last Year

+1 375 760 USD

Current Quarter

+202 450 USD

Last Quarter

+311 399 USD

Current Year

-2 410 176 USD

Last Year

+1 236 831 USD

Current Quarter

-634 031 USD

Last Quarter

-565 153 USD

Key Figures CYTH

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA -20 135 540 USD
Operating Margin TTM -2523.71 %
PE Ratio
Return On Assets TTM -223.69 %
PEG Ratio
Return On Equity TTM -22663.91 %
Wall Street Target Price 3.2 USD
Revenue TTM 1 126 444 USD
Book Value 0.021 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY 32.8 %
Dividend Yield
Gross Profit TTM 1 225 812 USD
Earnings per share -0.92 USD
Diluted Eps TTM -0.92 USD
Most Recent Quarter I 2024
Quarterly Earnings Growth YOY
Profit Margin

Dividend Analytics CYTH

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

Dividend History CYTH

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield
Last Split Factor 1:100
Payout Ratio
Last Split Date 09.12.2020
Dividend Date 09.12.2020

Stock Valuation CYTH

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE
Enterprise Value Revenue 25.9831
Price Sales TTM 33.6135
Enterprise Value EBITDA -1.3963
Price Book MRQ 7.606

Financials CYTH

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators CYTH

For 52 weeks

0.89 USD 2.18 USD
50 Day MA 1.33 USD
Shares Short Prior Month 28 419
200 Day MA 1.44 USD
Short Ratio 0.8
Shares Short 20 831
Short Percent 0.12 %

Dynamics of changes in the value of assets

Stocks


MSFT

MSFT

446.34 USD Microsoft Corporation -3.37 (-0.75%)
Detailed analytics

ETF funds


S

SLICHA

203.95 CHF UBS SLI A-dis -0.06 (-0.02%)
Detailed analytics

Metals


Gold

2339.94 USD Gold +11.09 (+0.48%)
Detailed analytics